Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher M. Smith currently holds 223,492 shares of NEOGENOMICS INC (NEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher M. Smith has been a net buyer of NEO stock. They have purchased $337.5M and sold $8.0M worth of shares.
Christopher M. Smith's most recent insider trade was on Jun 3, 2026, when they sold 223,492 shares at $0.00 per share.
Christopher M. Smith serves as Executive at NEOGENOMICS INC (NEO). They have executed 26 insider transactions totaling $345.5M over their tenure at the company.
Christopher M. Smith holds the position of Executive at NEOGENOMICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Christopher M. Smith has shown a buying trading pattern, with $337.5M in total purchases and $8.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher M. Smith was on May 6, 2014, when they purchased $337.5M worth of UBI shares. This transaction involved 30,000 shares at $11249.95 per share.
Christopher M. Smith currently owns 223,492 shares of NEOGENOMICS INC (NEO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher M. Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher M. Smith has 26 Form 4 filings on record as an insider at NEOGENOMICS INC.
Set alerts for Christopher M. Smith and 40,000+ other insiders.